Author
Listed:
- Mengmeng Zhao
(Tongji University School of Medicine)
- Gang Xue
(Sichuan University
Sichuan University)
- Bingxi He
(Beihang University
Ministry of Industry and Information Technology
Chinese Academy of Sciences)
- Jiajun Deng
(Tongji University School of Medicine)
- Tingting Wang
(Fudan University)
- Yifan Zhong
(Tongji University School of Medicine)
- Shenghui Li
(Tongji University School of Medicine)
- Yang Wang
(Tongji University School of Medicine)
- Yiming He
(Tongji University School of Medicine
The First Affiliated Hospital of Nanchang University)
- Tao Chen
(Tongji University School of Medicine)
- Jun Zhang
(Tailai Inc)
- Ziyue Yan
(Tailai Inc)
- Xinlei Hu
(Sichuan University
Sichuan University)
- Liuning Guo
(Zunyi Medical College)
- Wendong Qu
(Zunyi Medical College)
- Yongxiang Song
(Zunyi Medical College)
- Minglei Yang
(Chinese Academy of Sciences)
- Guofang Zhao
(Chinese Academy of Sciences)
- Bentong Yu
(The First Affiliated Hospital of Nanchang University)
- Minjie Ma
(The First Hospital of Lanzhou University)
- Lunxu Liu
(Sichuan University)
- Xiwen Sun
(Tongji University School of Medicine)
- Yunlang She
(Tongji University School of Medicine)
- Dan Xie
(Sichuan University
Sichuan University)
- Deping Zhao
(Tongji University School of Medicine)
- Chang Chen
(Tongji University School of Medicine)
Abstract
Diagnosing lung cancer from indeterminate pulmonary nodules (IPLs) remains challenging. In this multi-institutional study involving 2032 participants with IPLs, we integrate the clinical, radiomic with circulating cell-free DNA fragmentomic features in 5-methylcytosine (5mC)-enriched regions to establish a multiomics model (clinic-RadmC) for predicting the malignancy risk of IPLs. The clinic-RadmC yields an area-under-the-curve (AUC) of 0.923 on the external test set, outperforming the single-omics models, and models that only combine clinical features with radiomic, or fragmentomic features in 5mC-enriched regions (p
Suggested Citation
Mengmeng Zhao & Gang Xue & Bingxi He & Jiajun Deng & Tingting Wang & Yifan Zhong & Shenghui Li & Yang Wang & Yiming He & Tao Chen & Jun Zhang & Ziyue Yan & Xinlei Hu & Liuning Guo & Wendong Qu & Yongx, 2025.
"Integrated multiomics signatures to optimize the accurate diagnosis of lung cancer,"
Nature Communications, Nature, vol. 16(1), pages 1-16, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-024-55594-z
DOI: 10.1038/s41467-024-55594-z
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-024-55594-z. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.